HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Franco Lori Selected Research

Didanosine (Videx)

7/2005Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanisms.
4/2005Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency.
2/2004Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions.
1/2004T-cell receptor excision circles (TREC) in SHIV 89.6p and SIVmac251 models of HIV-1 infection.
1/2003Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concerns.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Franco Lori Research Topics

Disease

8Acquired Immunodeficiency Syndrome (AIDS)
01/2012 - 02/2002
7HIV Infections (HIV Infection)
01/2006 - 03/2002
6Infections
10/2011 - 02/2002
6Sexually Transmitted Diseases (Sexually Transmitted Disease)
05/2007 - 02/2002
3Viremia
05/2007 - 03/2002
2Vaccinia
09/2008 - 05/2003
2Pancreatitis
07/2005 - 01/2003
2Persistent Infection
01/2005 - 02/2002
1COVID-19
10/2021
1Communicable Diseases (Infectious Diseases)
10/2011
1Neoplasms (Cancer)
10/2011
1Erythema
01/2006

Drug/Important Bio-Agent (IBA)

6DermaVirIBA
10/2011 - 01/2005
6Hydroxyurea (Hydrea)FDA LinkGeneric
07/2005 - 01/2003
5Didanosine (Videx)FDA LinkGeneric
07/2005 - 01/2003
4Pharmaceutical PreparationsIBA
04/2005 - 03/2002
3Antiviral Agents (Antivirals)IBA
10/2021 - 07/2005
3VaccinesIBA
10/2011 - 01/2004
3Stavudine (Zerit)FDA LinkGeneric
04/2005 - 01/2003
2Cytostatic AgentsIBA
03/2008 - 07/2005
1remdesivirIBA
10/2021
1RNA (Ribonucleic Acid)IBA
01/2012
1DNA (Deoxyribonucleic Acid)IBA
10/2011
1HIV AntigensIBA
10/2011
1Interleukin-15 (Interleukin 15)IBA
09/2008
1Proteins (Proteins, Gene)FDA Link
09/2007
1CholesterolIBA
05/2007
1Triglycerides (Triacylglycerol)IBA
05/2007
1DNA VaccinesIBA
01/2006
1Viral DNAIBA
01/2006
14- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA
04/2005
1Peptide Hydrolases (Proteases)FDA Link
02/2004
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
02/2004
1Indinavir (Crixivan)FDA Link
02/2004
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2004
1Biomarkers (Surrogate Marker)IBA
01/2004
1Peptides (Polypeptides)IBA
05/2003
1AntigensIBA
05/2003
1HLA-DR Antigens (HLA-DR)IBA
05/2003

Therapy/Procedure

10Therapeutics
01/2012 - 02/2002
5Highly Active Antiretroviral Therapy (HAART)
05/2007 - 03/2002
1Salvage Therapy
08/2002